About the Authors

Tomas Kalincik

tomas.kalincik@unimelb.edu.au

Affiliations Department of Neurology and Center of Clinical Neuroscience, 1st Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic, Melbourne Brain Centre, Department of Medicine, University of Melbourne, Melbourne, Australia

Manuela Vaneckova

Affiliation Department of Radiology, 1st Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic

Michaela Tyblova

Affiliation Department of Neurology and Center of Clinical Neuroscience, 1st Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic

Jan Krasensky

Affiliation Department of Radiology, 1st Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic

Zdenek Seidl

Affiliation Department of Radiology, 1st Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic

Eva Havrdova

Affiliation Department of Neurology and Center of Clinical Neuroscience, 1st Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic

Dana Horakova

Affiliation Department of Neurology and Center of Clinical Neuroscience, 1st Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic

Competing Interests

The authors have read the journal’s policy and have the following conflicts: TK received compensation for travel and honoraria from Biogen Idec, Sanofi Aventis, Teva and Merck Serono. MV received compensation for travel and honoraria from Biogen Idec. MT received compensation for travel and honoraria from Biogen Idec, Sanofi Aventis, Teva and Merck Serono. JK received compensation for travel and honoraria from Biogen Idec and Sanofi Aventis. ZS received compensation for travel and honoraria from Biogen Idec. EH received speaker honoraria and consultant fees from Biogen Idec, Merck Serono, Novartis, Genzyme and Teva, as well as support for research activities from Biogen Idec and Merck Serono. DH received speaker honoraria and consultant fees from Biogen Idec, Novartis, Merck Serono and Bayer Shering, as well as support for research activities from Biogen Idec. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: EH DH TK MV ZS. Performed the experiments: MT JK DH. Analyzed the data: TK. Wrote the paper: TK. Designed the software used in analysis: JK.